Selected article for: "acute myeloid leukemia and myeloid leukemia"
Author: Cho, Sung-Yeon; Lee, Hyeon-Jeong; Lee, Dong-Gun
Title: Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
  • Document date: 2018_2_27
    • ID: t9tysvr8_63
    Snippet: Tuberculosis (TB) is an important opportunistic infection among HSCT recipients, in whom its incidence is 2-to 40-fold higher than that in the general population; however, this is lower than in solid-organ-transplant patients [145] [146] [147] . HSCT recipients are immunosuppressed as a result of their hematologic disease, chemotherapy, radiotherapy, immunosuppressive agents, and GVHD [146] . Several risk factors for the development of TB after H.....
    Document: Tuberculosis (TB) is an important opportunistic infection among HSCT recipients, in whom its incidence is 2-to 40-fold higher than that in the general population; however, this is lower than in solid-organ-transplant patients [145] [146] [147] . HSCT recipients are immunosuppressed as a result of their hematologic disease, chemotherapy, radiotherapy, immunosuppressive agents, and GVHD [146] . Several risk factors for the development of TB after HSCT have been reported, including acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome, busulfan, cyclophosphamide, TBI, corticosteroid therapy, HLA-mismatched transplant, GVHD, or a history of TB infection [148] . Of HSCT patients who develop TB, 80% and 20% had undergone allogeneic and autologous transplant, respectively.

    Search related documents:
    Co phrase search for related documents
    • autologous transplant and hsct patient: 1
    • autologous transplant and risk factor: 1
    • corticosteroid therapy and general population: 1, 2, 3, 4, 5, 6
    • corticosteroid therapy and opportunistic infection: 1
    • corticosteroid therapy and organ transplant: 1, 2, 3
    • corticosteroid therapy and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • corticosteroid therapy and solid organ transplant: 1, 2
    • corticosteroid therapy and tb infection: 1
    • general population and hematologic disease: 1, 2, 3, 4, 5, 6, 7, 8
    • general population and organ transplant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • general population and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • general population and solid organ transplant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • general population and solid organ transplant patient: 1
    • general population and TB development: 1
    • general population and tb infection: 1, 2, 3
    • hematologic disease and organ transplant: 1, 2, 3, 4
    • hematologic disease and risk factor: 1
    • hematologic disease and solid organ transplant: 1, 2, 3
    • hematologic disease and solid organ transplant patient: 1